Alzheimer's Drug Discovery Foundation - Programme to Accelerate Clinical Trials ($ 1,000,000)
The Alzheimer's Drug Discovery Foundation (ADDF) invites applications for its Programme to Accelerate Clinical Trials for Alzheimer's Disease. The upcoming deadline for submission of a full proposal is September 5, 2013. The Letter of Intent is due two weeks before the proposal deadline. The goal of the programme is to increase the number of innovative drugs tested in humans for Alzheimer’s disease. ADDF will fund biomarker-based pilot clinical trials. Funding is up to $1,000,000 per application.
ADDF funds drug discovery research programmes from investigators in academia and biotechnology companies. In addition, ADDF initiates, sponsors, and co-sponsors conferences to stimulate new ideas and approaches in areas of interest to the Foundation, bringing together physicians, scientists, and policy makers worldwide.